Diabetic neuropathy was the subject of a dedicated plenary session at the congress of the Francophone Diabetes Society. This already prevalent issue is becoming more prevalent and remains inadequately ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. About one in five adults with type 1 diabetes reports ...

The Diabetic Neuropathy Management market is poised for growth, driven by rising demand for early diagnosis, novel therapies, ...

With over 10 crore people living with diabetes in India, diabetic neuropathy remains a commonly observed complication, with ...

Study results show high treatment discontinuation and low adherence among US adults with painful diabetic peripheral neuropathy.

Diabetic neuropathy encompasses a spectrum of nerve disorders caused by chronic hyperglycaemia and metabolic dysregulation in patients with type 1 and type 2 diabetes. The most prevalent form is ...

Please provide your email address to receive an email when new articles are posted on . Diabetic peripheral neuropathy is associated with a decline in cognition for people with type 2 diabetes, ...

Diabetic peripheral neuropathy above a certain vibration perception threshold is linked to a notably higher risk for dementia in patients with type 2 diabetes, according to a Danish cohort study.

Neuropathy – chronic pain, numbness and tingling in the hands and feet – is a challenging fact of life for many patients with Type 1 diabetes. Thanks to a new National Institutes of Health grant, a ...

Share on Pinterest Spinal cord stimulation is now used to treat a number of conditions. milorad kravic/Getty Images Spinal cord stimulation is a treatment in which a device is implanted under the skin ...

Credit: Getty Images. The FDA has approved Qutenza® (capsaicin 8% patch; Averitas Pharma) for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet. The Food and ...